Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists

Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of Neurologists

BackgroundIn multiple sclerosis (MS), bridging therapies are usually administered when switching from one therapy to another. Such treatments generally consist of injectable immunomodulatory drugs (interferon or glatiramer acetate), whose efficacy, safety, and tolerability data are consolidated for...

Full description

Bibliographic Details
Main Authors: Girolama Alessandra Marfia, Diego Centonze, Marco Salvetti, Elisabetta Ferraro, Valentina Panetta, Claudio Gasperini, Massimiliano Mirabella, Antonella Conte
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Neurology
Subjects:
multiple sclerosis
bridging therapy
Delphi survey
MS management
injectable immunomodulatory drugs
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.898741/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.898741/full

Similar Items